Background

Osteoarthritis (OA), the most common form of arthritis, is a degenerative disease affecting the hands, knees, hips, feet and spine. It is caused by changes in cartilage, the soft tissue that cushions and protects bone, leading to pain and changes in the shape of the joint. In knee OA, as the cartilage wears away, the bone ends may begin to rub against each other, causing severe pain.

Joint unloading is a proven therapy that has become more common as the need for alternatives to end-stage joint replacement becomes more evident. Moximed’s KineSpring System is a joint unloading device available in Europe that has demonstrated clinical success in younger or active patients.

Moximed came to Halsin Partners to help launch the KineSpring System in several European countries, including Germany, Italy, the UK and Spain.

Objectives

Across Europe, the aim of the program was to generate awareness and highlight the benefits of the KineSpring System amongst orthopedic surgeons and patients.

Strategy & Implementation

As part of the campaign in Italy, the Halsin team organized a press roundtable during the European Knee Association (EKA) meeting in Florence. Three leading KOLs participated in the event to help explain how the KineSpring System benefits patients and fits into the OA treatment paradigm.